Anlotinib in Recurrent or Metastatic Nasopharyngeal Carcinoma Patients After Failure of no Less Than Second-line Therapy
Clinical trial NCT03906058 · COMPLETED
Trial details
- NCT number
- NCT03906058
- Sponsor
- Sun Yat-sen University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-29
- Primary completion
- 2021-02-27
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.